The company
Protagonist Therapeutics, Inc.
PTGX · Nasdaq
PTGX stood above a rising 150-day average in 52 of the last 52 weekly readings, every one of them. It is 4.6% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 52 in a row
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $181.9M
- Officials’ trades on record
- 2
- Institutions holding
- 320 (+28)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 52 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
2 disclosed lines: House 0, Senate 0, executive 2; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 15 May 2026filed 1 Jul 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Asif AliChief Financial Officer | sold | 12,595at $141.77 | 30 Sep 2026filed 2 Oct 2026 |
| Asif AliChief Financial Officer | sold | 46,034at $141.78 | 30 Sep 2026filed 2 Oct 2026 |
| Dinesh V. Ph D. PatelPresident and CEO | sold | 7,278at $144.10 | 10 Sep 2026filed 10 Sep 2026 |
| Dinesh V. Ph D. PatelPresident and CEO | sold | 63,548at $146.18 | 9 Sep 2026filed 10 Sep 2026 |
| Dinesh V. Ph D. PatelPresident and CEO | sold | 54,174at $145.87 | 8 Sep 2026filed 10 Sep 2026 |
| Dinesh V. Ph D. PatelPresident and CEO | sold | 34,239at $148.52 | 11 Aug 2026filed 12 Aug 2026 |
| Dinesh V. Ph D. PatelPresident and CEO | sold | 65,761at $149.11 | 10 Aug 2026filed 12 Aug 2026 |
| William D. WaddillDirector | sold | 9,000at $117.94 | 23 Jun 2026filed 25 Jun 2026 |
| William D. WaddillDirector | sold | 9,000at $107.68 | 10 Jun 2026filed 11 Jun 2026 |
| William D. WaddillDirector | sold | 9,000at $99.64 | 29 May 2026filed 1 Jun 2026 |
| Dinesh V. Ph D. PatelPresident and CEO | sold | 75,000at $100.12 | 12 May 2026filed 12 May 2026 |
| Dinesh V. Ph D. PatelPresident and CEO | sold | 75,000at $100.12 | 12 May 2026filed 14 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 10,307,837$1.3B | +528,468+5.4% |
| FARALLON CAPITAL MANAGEMENT, L.L.C.unchanged · filed 14 Aug 2026 | 6,348,906$778.2M | 00.0% |
| RTW INVESTMENTS, LPadded · filed 14 Aug 2026 | 5,061,175$620.4M | +2,1220.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLCnew · filed 13 Aug 2026 | 3,629,298$444.9M | +3,629,298 |
| WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 2026 | 3,416,781$418.8M | -182,863−5.1% |
| UBS Group AGreduced · filed 13 Aug 2026 | 3,399,221$416.7M | -1,778,575−34.4% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,321,554$407.2M | +204,805+6.6% |
| VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 2026 | 2,853,394$349.8M | +2,853,394 |
| JOHNSON & JOHNSONunchanged · filed 6 Aug 2026 | 2,449,183$300.2M | 00.0% |
| Invesco Ltd.added · filed 14 Aug 2026 | 2,340,667$286.9M | +175,997+8.1% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.